GDP in the US: USP Chapter and Stimuli Article on MKT
Recommendation

Tuesday, 29 September 2026 14.00 - 16.00 h
GDP-compliant Transport Processes: from Risk Assessment to Practical Implementation
In the Pharmacopeial Forum, PF 49(2), a proposal for a revised USP General Chapter <1079.2> "Mean Kinetic Temperature in the Evaluation of Temperature Excursions During Storage and Transportation of Drug Products" and a Stimuli Article "The Use of Mean Kinetic Temperature and the Need of Allowable Excursion Limits for Climatic Zone IVb" were published.
The background is that the United States Pharmacopeia (USP) is proposing the inclusion of temperature excursion limits for climatic zone IVb. Currently, Chapter <1079.2> contains only temperature excursion limits for climatic zone II.
As already reported in February, both documents, the revised Chapter <1079.2> and the Stimuli Article, were pre-posted prior to their publication in the Pharmacopeial Forum. According to the USP, this was to allow stakeholders additional time for reading and understanding.
For a summary of the changes and contents, please have a look at our news archive.
The documents are available on PF Online. Comments can be submitted until 31 May 2023.
Related GMP News
10.09.2026European GDP Association Developments May through August 2026
10.09.2026Reminder: Submit your Presentation Proposal for the GDP Forum 2027 by 30 September
10.09.2026GDP in the US: FDA Launches DSCSA Assessment for Small Dispensers and Issues Exemptions
11.08.2026GDP for APIs: APIC Publishes Updated "How to Do" Document
11.08.2026Where to Find Information on UK Wholesale Authorisations


